Tirofiban for recent mild stroke or TIA with narrowed brain artery
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests the drug tirofiban (a blood thinner) to prevent another stroke in people who have had a mild stroke or high-risk TIA and have a narrowed artery in the brain. It must be started within 24 hours of symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years old or older.
- You had a mild stroke (NIHSS 5 or less) or a high-risk TIA (ABCD2 score 6 or more) with a narrowed brain artery seen on imaging.
- The study drug can be started within 24 hours of your first symptoms.
- You do not have bleeding problems, kidney or liver failure, or other serious conditions that would make tirofiban unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called tirofiban can help prevent stroke symptoms from getting worse after receiving a clot-busting drug. It is for patients with a narrowed brain artery and ongoing moderate to severe symptoms.
This study tests whether adding a drug called tirofiban to aspirin can improve recovery outcomes in people who have had a moderate stroke. Tirofiban helps prevent new blood clots from forming, which may reduce the risk of further stroke and disability.
This trial tests whether giving tirofiban (a blood thinner) shortly after the standard clot-busting drug tenecteplase can improve recovery from a moderate stroke. It is for people who have had a stroke within the last few hours and do not have certain risk factors like irregular heart rhythm or recent bleeding.
This trial tests whether a drug called tirofiban can help people who had a stroke more than 24 hours ago but within 7 days. It is for strokes caused by a buildup of plaque in a large brain artery, and uses a special MRI to confirm the cause.
This trial tests if adding a blood thinner called tirofiban after successful clot removal can improve recovery in people with severe stroke. It is for patients who had a large blockage and are treated within 24 hours of symptoms starting.
This trial tests whether a combination of a clot-preventing drug (tirofiban) followed by two antiplatelet drugs (aspirin and clopidogrel) can improve recovery in people who have had a mild stroke. It aims to find a better way to prevent further strokes or worsening symptoms.
Hear when a new TIA trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.